Details for Patent: 6,335,369
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 6,335,369
| Title: | Treating chronic uremic patients undergoing periodical dialysis |
| Abstract: | Chronic uremic patients undergoing periodical dialysis are treated with carnitine or one of its salts to prevent or treat carnitine deficiency in patients with end stage renal disease. An effective dose of carnitine, preferably L-carnitine fumarate, is administered preferably intravenously into the venous return line after each dialysis session. |
| Inventor(s): | Cavazza; Claudio (Rome, IT) |
| Assignee: | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (Rome, IT) |
| Application Number: | 09/761,639 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 6,335,369
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,335,369
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 3050201 | See Plans and Pricing | |||
| Canada | 2381187 | See Plans and Pricing | |||
| European Patent Office | 1257266 | See Plans and Pricing | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
